An immunoblot analysis of EpCAM, E-cadherin (known epithelial cell markers), and vimentin (known mesenchymal cell markers) was performed to determine the effect of PYCR2 upon cancer cell phenotype [39,40,41]. This evidence concerns the gene CDH1 and cancer.